Literature DB >> 31121181

Molecular Engineering of the TGF-β Signaling Pathway.

Zhike Zi1.   

Abstract

Transforming growth factor beta (TGF-β) is an important growth factor that plays essential roles in regulating tissue development and homeostasis. Dysfunction of TGF-β signaling is a hallmark of many human diseases. Therefore, targeting TGF-β signaling presents broad therapeutic potential. Since the discovery of the TGF-β ligand, a collection of engineered signaling proteins have been developed to probe and manipulate TGF-β signaling responses. In this review, we highlight recent progress in the engineering of TGF-β signaling for different applications and discuss how molecular engineering approaches can advance our understanding of this important pathway. In addition, we provide a future outlook on the opportunities and challenges in the engineering of the TGF-β signaling pathway from a quantitative perspective.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Smad; TGF-beta; protein engineering; synthetic biology

Mesh:

Substances:

Year:  2019        PMID: 31121181     DOI: 10.1016/j.jmb.2019.05.022

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Identification of a transforming growth factor-β type I receptor transcript in Eriocheir sinensis and its molting-related expression in muscle tissues.

Authors:  Zhihuan Tian; Hongyuan Peng; Weide Deng; Chuanzhen Jiao
Journal:  Mol Biol Rep       Date:  2019-09-30       Impact factor: 2.316

2.  A Novel MicroRNA and the Target Gene TAB2 Can Regulate the Process of Sucking Blood in and the Spawn Rate of Hyalomma asiaticum (Acari: Ixodidae) Ticks.

Authors:  Jin Luo; Feng Wu; Wenge Liu; Qiaoyun Ren; Peiwen Diao; Guiquan Guan; Jianxun Luo; Hong Yin; Guangyuan Liu
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Assessment of the TGFB1 gene expression and methylation status of the promoter region in patients with colorectal cancer.

Authors:  Damian Wodziński; Agnieszka Wosiak; Jacek Pietrzak; Rafał Świechowski; Radzisław Kordek; Ewa Balcerczak
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

4.  Animal study of a newly designed metal airway brachytherapy stent loaded with radioactive 125I seeds.

Authors:  Dechao Jiao; Qinyu Lei; Kaihao Xu; Yiming Liu; Xinwei Han
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-03       Impact factor: 4.322

5.  SMAD4 mutations identified in Iranian patients with colorectal cancer and polyp.

Authors:  Rouhallah Najjar Sadeghi; Nastaran Saeedi; Negar Sahba; Amir Sadeghi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

Review 6.  Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin.

Authors:  Devesh Tewari; Anu Priya; Anusha Bishayee; Anupam Bishayee
Journal:  Clin Transl Med       Date:  2022-04

Review 7.  From the Performance to the Essence: The Biological Mechanisms of How Tantalum Contributes to Osteogenesis.

Authors:  Hu Qian; Ting Lei; Zhimin Ye; Yihe Hu; Pengfei Lei
Journal:  Biomed Res Int       Date:  2020-07-27       Impact factor: 3.411

8.  N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.

Authors:  Zhenyu Zhao; Qidong Cai; Pengfei Zhang; Boxue He; Xiong Peng; Guangxu Tu; Weilin Peng; Li Wang; Fenglei Yu; Xiang Wang
Journal:  Front Mol Biosci       Date:  2021-06-11

9.  Constructing a new prognostic signature of gastric cancer based on multiple data sets.

Authors:  Liqiang Zhou; Hao Lu; Fei Zeng; Qi Zhou; Shihao Li; You Wu; Yiwu Yuan; Lin Xin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

10.  miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.

Authors:  Hao Wang; Zeng Wang; Yirui Wang; Xiangcheng Li; Wenjie Yang; Song Wei; Chengyu Shi; Jiannan Qiu; Ming Ni; Jianhua Rao; Feng Cheng
Journal:  J Cell Mol Med       Date:  2021-07-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.